Most everyone would agree that 2007 was a very good year, except for the last few months when subprime loans and housing issues dominated the news. The analytical and life science instrument industry turned in an unexpectedly strong performance. Instrument companies continued to focus on emerging markets. Biotech spending was robust and pharmaceutical expenditures improved […]
Laboratory automation equipment can increase laboratory efficiency, especially in areas where processes depend on repetition and precision. Lab automation is also a way to increase productivity, throughput and, perhaps, most importantly, lower the cost per sample analyzed. In 2007, growth for the overall lab automation market was disappointing. Historically, the automation market grows between 7% […]
Although recent financial difficulties have curtailed global GDP growth estimates for 2008, the Organization for Economic Cooperation and Development (OECD) argues that the US subprime mortgage crisis, slowdowns in worldwide housing markets, and rising energy and commodity prices are all occurring within a generally robust global economy that is benefiting from high employment rates, strong […]
With the IBO Laboratory Instrumentation and Consumables Stock Indexes up over 20% for the second year in a row, it would seem that one would only have had to throw darts at the list of our industry equities to easily come up with winners. Alas that was not the case for our stock picks for […]
In 2007, several analytical instrument and laboratory product companies went public. However, as shown below, the stock prices for most of these companies were unable to prosper under this year’s volatile market conditions. The best performing IPO was DNA sequencer developer Helicos Biosciences (see IBO 5/31/07). The company, which has yet to officially release its […]
The major US stock markets managed to sustain positive gains in 2007 for the fifth consecutive year, despite extreme market volatility caused by the credit crisis and housing downturn. Strong corporate earnings and the Federal Reserve’s cuts in interest rates were enough to overcome selling pressure in the major US markets, which finished the year […]
The announcement of the US federal budget for fiscal year 2008 (October 1, 2007–September 30, 2008) was grim news for science R&D supporters. According to a preliminary analysis by the American Association for the Advancement of Science (AAAS), the total US federal R&D budget increased only 1.2% for fiscal 2008 to $142,715 million. This amount […]
Third quarter 2007 IBO Life Science Index sales gained 12.4% to $2,098 million, compared to 8.5% in the same period last year. While favorable currency transactions contributed to overall Index growth, organic revenues sustained significant increases. Operating profit for the Index jumped 29.7% to $311 million and operating margin gained 200 basis points to 14.8% […]
An article in the November 15, 2007, issue of IBO discussed increased concerns about food imports, particularly from China. On December 11, the US and China announced a formal agreement to improve food safety. The agreement applies to four products categories: “low-acid canned products or acidified food”; “pet food/pet treats of plant origin or animal […]
Microliter spectrophotometry is a technique used to measure extremely small sample sizes, but its market potential is anything but small. Recent activity in the market has reflected both large and small companies’ recognition of the prospects of microliter spectrophotometry. In October, Thermo Fisher Scientific acquired NanoDrop (see IBO 10/15/07), the market leader. Next year, GE […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
